Surgery Partners, Inc.
SGRY
$17.07
$0.010.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -171.40M | -180.40M | -193.40M | -168.10M | -60.60M |
| Total Depreciation and Amortization | 150.00M | 160.70M | 155.20M | 152.60M | 149.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 427.20M | 416.90M | 441.70M | 434.50M | 315.20M |
| Change in Net Operating Assets | -123.50M | -133.30M | -138.10M | -118.90M | -153.10M |
| Cash from Operations | 282.30M | 263.90M | 265.40M | 300.10M | 251.30M |
| Capital Expenditure | -88.20M | -88.60M | -92.10M | -90.40M | -87.90M |
| Sale of Property, Plant, and Equipment | 44.00M | 44.00M | 5.90M | 2.60M | 1.50M |
| Cash Acquisitions | -140.20M | -162.20M | -368.20M | -378.80M | -322.40M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.80M | -28.80M | -27.40M | -21.90M | -26.10M |
| Cash from Investing | -232.20M | -235.60M | -481.80M | -488.50M | -434.90M |
| Total Debt Issued | 776.00M | 816.50M | 1.75B | 1.73B | 2.17B |
| Total Debt Repaid | -630.90M | -604.90M | -1.28B | -1.28B | -1.81B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -213.60M | -203.30M | -211.90M | -188.40M | -192.80M |
| Cash from Financing | -68.50M | 8.30M | 260.50M | 262.00M | 169.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.40M | 36.60M | 44.10M | 73.60M | -14.20M |